Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gatemore Capital Management is an investment management firm and principal investor, not a life sciences, biotech, pharma, or healthcare operating company. The firm focuses on special situations and growth opportunities across sectors including consumer, industrial, sports, media, technology, and selectively healthcare as an investment sector. Publicly available materials describe Gatemore as an independent investment firm with hedge fund and principal investing activities rather than a developer of therapeutics, diagnostics, or medical technologies. As a result, it does not appear to have a drug pipeline, therapeutic programs, or proprietary healthcare products in the sense typically used for biotech company profiling.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gatemore Capital Management.